Blog

Regular posts covering guidance changes, inspection findings, data methodology, and Redica product updates.

Redica Expands Global Inspection Coverage with New PMDA, Swissmedic, EMA, and MFDS Data
Company News

Redica Expands Global Inspection Coverage with New PMDA, Swissmedic, EMA, and MFDS Data

January 28, 2026
Scott Sherrill
featured

Latest Blog Posts

Conference Spotlight

Facility Issues Top Inspection Deficiencies for Biologics

November 12, 2024
BLAs
CDER
OPMA
OPQ
PDA/FDA
Trends

How Much Can Poor Quality Cost You?

November 8, 2024
483
483 observation
483 response
Cost of Quality
Quality
Enforcement

Navigating FDA Guidelines for Combination Products: A Comprehensive Guide

November 6, 2024
Combination Products
FDA Database
FDA Approval
Guidelines
medical devices

KVK-Tech Warning Letters: A Timeline of Regulatory Assessments

October 30, 2024
No items found.
Enforcement

ICH Q9 Quality Risk Management in Pharma

October 15, 2024
ICH
ICH Q9
Pharma
QRM
Quality Risk Management
Enforcement

FDA Inspection Shows Systemic Data Falsification Issues

October 11, 2024
483
API
API Manufacturer
Data Falsification
view all

Company news

view all
Company News

Redica Expands Global Inspection Coverage with New PMDA, Swissmedic, EMA, and MFDS Data

January 28, 2026
Company News

Redica Systems Announces $30M Series B

December 9, 2021

Conference Spotlight

view all
Conference Spotlight

FDA: A Pillar of Protection for Patients and Industry

April 4, 2025
Conference Spotlight

Facility Issues Top Inspection Deficiencies for Biologics

November 12, 2024
Conference Spotlight

Who is Responsible When GMPs Are Not Followed?

October 9, 2024
Conference Spotlight

What is a VAI or OAI Regulatory Meeting?

October 2, 2024

Enforcement

view all
Enforcement

Limiting Plant Access and Sharing Redacted Documents Results in Import Alert and Warning Letter

January 28, 2025
Enforcement

Granules India FDA 483 Includes Potential Contamination and Data Integrity Findings

November 26, 2024
Enforcement

Navigating FDA Guidelines for Combination Products: A Comprehensive Guide

November 6, 2024
Enforcement

ICH Q9 Quality Risk Management in Pharma

October 15, 2024

Inspection Intelligence

view all
No items found.

Post-market Intelligence

view all
Post-Market Intelligence

FDA PreCheck Initiative Draws Strong Industry Reaction at Recent Stakeholder Meeting

December 1, 2025

Product News

view all
No items found.

Regulatory Intelligence

view all
No items found.

Site Intelligence

view all
No items found.
Alison Sathe
Anders Vinther
Arijit Saha
Ayan Ghosh
Barbara W. Unger
Jackie Torfin
Jerry Chapman
Jon Falker
Katie Terry
Mark Agostino
Rebecca Stauffer
Redica Systems
Roger Angarita
Sarah Boynton
Sarah Kotler
Scott Sherrill
Yelena Ionova
101
2011 process validation guidance
2022 PDA Annual Meeting
2024 highlights
483
483 Findings
483 Response Letter
483 observation
483 observations
483 response
503A
503B
503B outsourcing
510k
510k submission
AI
AI-Powered
ALCOA
ALCOA-C,
ANMAT
APAC
APAC
API
API Manufacturer
Alison Sathe
Anne Johnson
Argentina
Asia-Pacific
Audit
BIMO
BLAs
Biologics
Bob McDowall
CAPA
CAPA System
CBER
CDER
CDER Updates
CDMO
CFR
CGMP
CGT
CMC
CMO
COFEPRIS
CPAP Machines
CPO
CROs
CVM
Case Study
Catalyst
Cell and Gene
China
Clinical Trial Guidance
Code of Federal Regulations
Colombia
Combination Products
Combination Products
Comparison report
Compliance
ConOps
Contamination
Context Engineering
Contract Facilities
Cost of Quality
DCT
DEG
DEG-contaminated
DEG/EG
DIGEMID
DOJ
DaaS
Data Enrichment
Data Explorer
Data Falsification
Data Governance
Data Ingegrity
Data Integrity
Data Manipulation
Data Operations
Data Sources
Data integirty
Data-as-a-service
Devices
Devies
Digital IT Teams
Document Store
Donald Ashley
Draft Guidance
Drug Approval
Drug Approvals
Drug Manufacturing
Drug Shortages
Drug Shortages
Drug recalls
Dupont
EG
EIR
EIRs
EMA

Other Resources

Assessments

Insights on inspections, risk and compliance

Reports

Benchmark industry trends and best practices

Webinars

Hear from industry leaders and Redica experts.